Jan 24 (Reuters) - Novelion Therapeutics Inc:
* NOVELION THERAPEUTICS ANNOUNCES COST REDUCTION PLANS AND CAPITAL STRUCTURE REVIEW
* NOVELION THERAPEUTICS -ANNOUNCED COST REDUCTION PLANS AS IT MANAGES CASH RESOURCES, EFFECTS OF DELAY & UNCERTAINTY OF SETTLEMENT OF UNIT WITH DOJ, SEC
* NOVELION THERAPEUTICS - IN ADDITION TO WORKFORCE AND OTHER COST REDUCTIONS, PURSUING LICENSING OPPORTUNITIES FOR ITS ZURETINOL DRUG CANDIDATE Source text for Eikon: Further company coverage: